The indices may test intraday lows, which we haven't seen at this point in the day in a very long time.

Amgen Shows a Bullish Breakout Real Money Pro($)

There is more upside to come for this stock.
A trade at $126 will be a new high for the move up.

Biotech Buoyed by Deal Talk Real Money Pro($)

M&A activity is in a serious upswing, and here are some names to watch.

Bullish Momentum for Regeneron Real Money Pro($)

Volatility has calmed down, and there are bullish signs.
You need to see where the health services giant normally trades to appreciate how undervalued it is.
Don't fight the trend of this stock.
They can close out early if the trade isn't going their way.
We answer recent reader questions about three of the biotech stocks we regularly cover.
Static doesn't work in this industry. Pipelines work.

Columnist Conversations

I have a special guest joining me today, legendary technician Marc Chaikin comes aboard tonight, talking about...
View Chart »  View in New Window » To fail or not to fail is the question.  The video I d...
I've been suspect of CSCO since early this month and am still convinced a pullback is on the way. The stock h...
I forgot to list my short positions in RH puts in my disclosure on retail shares. Paul


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.